The 100mg vial offers better value per milligram and is more suitable for extended research timelines or higher-volume work
The animal literature is unusually consistent, though: nearly every published in vivo study used 5 mg/kg per injection, given three times on alternate days (days 1, 3, and 5, or days 14, 16, and 18 in the pulmonary fibrosis model), with effects tracked over the following three to four weeks
AOD-9604 adds a lipolytic component without further IGF-1 increase , useful in research contexts where you want lipolysis but not systemic anabolism
The cosmetic applications of GHK-Cu are the best clinically validated, with several commercialized products containing this peptide
Handling and Storage Recommendations Keep tightly closed at 20C , dry, and protected from light